Division of Hematology/Oncology and Department of Medicine, Rhode Island Hospital, Providence, RI, USA.
Mol Cancer. 2013 Oct 8;12(1):118. doi: 10.1186/1476-4598-12-118.
BACKGROUND: Extracellular vesicle (EV) trafficking is a fundamental cellular process that occurs in cells and is required for different aspects of pathophysiology. EV trafficking leads to changes in cellular function including apoptosis, angiogenesis and proliferation required for increased tumor formation. RESULTS: We report several phenotypic changes mediated by EVs isolated from non-malignant and malignant prostate cells as well as patient biopsied prostate tumor samples. EVs can reverse the resistance of prostate cancer cells to camptothecin EVs isolated from non-malignant PrECs (Prostate Epithelial Cells) can reverse soft agar colony formation of malignant DU145 cells, with the reciprocal effect observed. Isolation of EVs from 2 Gleason grade 8 prostate cancer patients significantly induced soft agar colony formation of non-malignant PrECs. We have identified proteins via antibody and Mass spectrometry analysis that may be responsible for the phenotypic changes. Mass spectrometry analysis of protein lysates using ProteoIQ revealed protein candidates associated with gene ontology annotations that may be responsible for this phenotypic change. Ingenuity Pathway Analysis was used to identify statistically relevant canonical pathways and functions associated the protein IDs and expression values obtained using ProteoIQ. Western blot analysis confirmed the increase of 14-3-3 zeta, pRKIP and prohibitin protein levels in PrEC cells co-cultured with patient EVs. 14-3-3 proteins were also found as common proteins of 3 other Gleason grade 8 patients. CONCLUSION: Our study provides a rational basis to further investigate putative proteins, such as 14-3-3 and prohibitin and genetic factors that may be responsible for phenotypic changes that are associated with prostate cancer progression.
背景:细胞外囊泡(EV)的转运是一种基本的细胞过程,发生在细胞中,是病理生理学不同方面所必需的。EV 的转运导致细胞功能的改变,包括细胞凋亡、血管生成和增殖,这些都是肿瘤形成所必需的。
结果:我们报告了从非恶性和恶性前列腺细胞以及患者活检的前列腺肿瘤样本中分离的 EV 介导的几种表型变化。EV 可以逆转前列腺癌细胞对喜树碱的耐药性,从非恶性 PrECs(前列腺上皮细胞)分离的 EV 可以逆转恶性 DU145 细胞的软琼脂集落形成,反之亦然。从 2 名 Gleason 分级 8 前列腺癌患者中分离的 EV 显著诱导非恶性 PrECs 的软琼脂集落形成。我们通过抗体和质谱分析鉴定了可能负责表型变化的蛋白质。使用 ProteoIQ 对蛋白质裂解物进行质谱分析揭示了与基因本体注释相关的可能负责这种表型变化的蛋白质候选物。使用 Ingenuity Pathway Analysis 确定了与使用 ProteoIQ 获得的蛋白质 ID 和表达值相关的统计学上相关的经典途径和功能。Western blot 分析证实了与患者 EV 共培养的 PrEC 细胞中 14-3-3zeta、pRKIP 和 prohibitin 蛋白水平的增加。还发现 14-3-3 蛋白是另外 3 名 Gleason 分级 8 患者的共同蛋白。
结论:我们的研究为进一步研究可能的蛋白质,如 14-3-3 和 prohibitin 以及可能与前列腺癌进展相关的表型变化相关的遗传因素提供了合理的依据。
Pharmaceuticals (Basel). 2023-11-16
Bioengineering (Basel). 2022-6-4
Cancer Drug Resist. 2021-3-19
Cancers (Basel). 2021-7-28
Int J Mol Sci. 2020-9-7
Cancers (Basel). 2020-5-29
Am J Physiol Cell Physiol. 2019-3-27
Int J Mol Sci. 2018-9-18
Blood Cancer J. 2012-3-9
Semin Cell Dev Biol. 2012-6-15
PLoS One. 2012-5-4
Mol Cell Proteomics. 2012-3-28